Lustra-af Generic Name & Formulations
Legal Class
Rx
General Description
Hydroquinone 4%; crm; contains sunscreens, sulfites.
Pharmacological Class
Depigmenting agent.
See Also
How Supplied
Crm—1oz, 2oz
Manufacturer
Lustra-af Indications
Indications
UV-induced skin dyschromia and discoloration due to hormonal changes or skin trauma.
Lustra-af Dosage and Administration
Adult
Apply to affected areas twice daily. Discontinue if lightening effect does not occur after 2 months.
Children
Not recommended.
Lustra-af Contraindications
Not Applicable
Lustra-af Boxed Warnings
Not Applicable
Lustra-af Warnings/Precautions
Warnings/Precautions
Do skin sensitivity test before use; do not use if itching, vesicle formation or excessive inflammation occurs. Avoid sun and UV light. Not for use as a sunscreen. Avoid eyes. Pregnancy (Cat.C). Nursing mothers.
Lustra-af Pharmacokinetics
See Literature
Lustra-af Interactions
Not Applicable
Lustra-af Adverse Reactions
Adverse Reactions
Contact dermatitis.
Lustra-af Clinical Trials
See Literature
Lustra-af Note
Not Applicable
Lustra-af Patient Counseling
See Literature